Tirosint Solution
Product Images NDC 71858-0135

21 FDA label images from Ibsa Pharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Tirosint (NDC 71858-0135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ibsa Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

As Tirosint Sol 100mcg Monodose 518814

As Tirosint Sol 100mcg Monodose   518814
Packaging label for Tirosint SOL 100 microgram/mL (levothyroxine sodium) oral solution by IBSA Pharma Inc., containing 6 pouches of 5 ampules each. The label includes storage, tamper-evidence, and oral use only instructions, along with manufacturer and distributor information.*
FDA Label Image

As Tirosint Sol 112mcg Monodose 518824

As Tirosint Sol 112mcg Monodose   518824
The image shows the packaging label for Tirosint SOL, an oral solution of levothyroxine sodium with a strength of 112 microgram/mL. The label indicates it contains 6 pouches, each with 5 ampules, and is marked Rx only. Manufacturer and distributor details for IBSA Pharma Inc. are provided, along with storage instructions and warnings about proper use.*
FDA Label Image

As Tirosint Sol 125mcg Monodose 518834

As Tirosint Sol 125mcg Monodose   518834
Tirosint SOL 125 microgram/mL (levothyroxine sodium) oral solution carton label for 6 pouches each containing 5 ampules. The package is labeled for oral use only, not for inhalation, injection, or ophthalmic use. The labeler is IBSA Pharma Inc., with manufacturing by IBSA Institut Biochimique SA, Switzerland.*
FDA Label Image

As Tirosint Sol 137mcg Monodose 518844

As Tirosint Sol 137mcg Monodose   518844
Packaging label for Tirosint SOL oral solution, containing levothyroxine sodium at a strength of 137 micrograms per milliliter. The box indicates a count of 6 pouches with 5 ampules each. Labeler is IBSA Pharma Inc., with manufacturing by IBSA Institut Biochimique SA in Switzerland. The label includes warnings that the solution is for oral use only and is not for inhalation, injection, or ophthalmic use.*
FDA Label Image

As Tirosint Sol 13mcg Monodose 518764

As Tirosint Sol 13mcg Monodose   518764
Packaging label for Tirosint SOL oral solution containing levothyroxine sodium at 13 microgram/mL concentration. The label indicates prescription use only and specifies a package content of 6 pouches each with 5 ampules. The labeler is IBSA Pharma Inc., and the product is for oral use only, not for inhalation, injection, or ophthalmic use.*
FDA Label Image

As Tirosint Sol 150mcg Monodose 518854

As Tirosint Sol 150mcg Monodose   518854
Packaging label for Tirosint SOL, Levothyroxine Sodium oral solution at 150 microgram/mL strength. The label indicates the product comes in 6 pouches with 5 ampules each and is for oral use only, not for inhalation, injection, or ophthalmic use. Manufactured for IBSA Pharma Inc., the label features the IBSA logo and includes storage and usage instructions.*
FDA Label Image

As Tirosint Sol 175mcg Monodose 518864

As Tirosint Sol 175mcg Monodose   518864
Packaging label for Tirosint SOL oral solution containing levothyroxine sodium at a strength of 175 microgram/mL. The label indicates the product is supplied in a package of 6 pouches with 5 ampules each. It is manufactured for IBSA Pharma Inc. and includes warnings that it is for oral use only and not for inhalation, injection, or ophthalmic use. The label also shows the NDC code 71858-0155-5 and essential storage and usage instructions.*
FDA Label Image

As Tirosint Sol 200mcg Monodose 518872

As Tirosint Sol 200mcg Monodose   518872
Packaging label for Tirosint SOL oral solution containing levothyroxine sodium at a strength of 200 micrograms per mL. The package includes 6 pouches, each containing 5 ampules. The label highlights that it is for oral use only and is not for inhalation, injection, or ophthalmic use. Manufactured and distributed by IBSA Pharma Inc.*
FDA Label Image

As Tirosint Sol 25mcg Monodose 518774

As Tirosint Sol 25mcg Monodose   518774
Packaging label for Tirosint SOL 25 microgram/mL (levothyroxine sodium) oral solution. The label indicates the product is for oral use only and comes in a package containing 6 pouches, each with 5 ampules. The manufacturer is IBSA Pharma Inc., with manufacturing by IBSA Institut Biochimique SA in Switzerland.*
FDA Label Image

As Tirosint Sol 37.5mcg Monodose 566222

As Tirosint Sol 37.5mcg Monodose   566222
Tirosint SOL 37.5 microgram/mL (levothyroxine sodium) oral solution packaging label. The box indicates 6 pouches with 5 ampules each, labeled for oral use only and not for inhalation, injection, or ophthalmic use. Manufactured by IBSA Pharma Inc., the label includes storage directions, dosage information prompts, and a tamper-evident warning.*
FDA Label Image

As Tirosint Sol 44mcg Monodose 566232

As Tirosint Sol 44mcg Monodose   566232
Carton label for Tirosint SOL (levothyroxine sodium) oral solution, 44 microgram/mL strength. The package contains 6 pouches, each with 5 ampules. Label includes a warning for oral use only and Rx only designation. Manufactured and distributed by IBSA Pharma Inc. The label features the IBSA logo and storage, usage, and tamper-evident instructions.*
FDA Label Image

As Tirosint Sol 50mcg Monodose 518784

As Tirosint Sol 50mcg Monodose   518784
Packaging label for Tirosint SOL (levothyroxine sodium) oral solution 50 microgram/mL. The package contains 6 pouches with 5 ampules each. Labeled for oral use only and manufactured for IBSA Pharma Inc. The IBSA logo is visible, along with storage and usage instructions and a barcode.*
FDA Label Image

As Tirosint Sol 62.5mcg Monodose 566242

As Tirosint Sol 62.5mcg Monodose   566242
Box packaging label for Tirosint SOL oral solution containing levothyroxine sodium at a strength of 62.5 microgram/mL. The label shows the product is for oral use only, packaged as 6 pouches each containing 5 ampules. Labeler is IBSA Pharma Inc., with manufacturing by IBSA Institut Biochimique SA, Switzerland.*
FDA Label Image

As Tirosint Sol 75mcg Monodose 518794

As Tirosint Sol 75mcg Monodose   518794
Packaging label for Tirosint SOL, 75 microgram/mL levothyroxine sodium oral solution. The label shows the product name, concentration, and oral solution dosage form. It indicates 6 pouches with 5 ampules each and includes usage directions emphasizing oral use only. Manufactured for IBSA Pharma Inc., with branding and contact information present.*
FDA Label Image

As Tirosint Sol 88mcg Monodose 518804

As Tirosint Sol 88mcg Monodose   518804
Packaging label for Tirosint SOL 88 microgram/mL oral solution containing levothyroxine sodium. The carton indicates 6 pouches with 5 ampules each, labeled for prescription use only. Manufactured for IBSA Pharma Inc., the label includes usage warnings and storage instructions, along with the IBSA logo and barcode.*
FDA Label Image

Chemical Structure (Tirosint 01)

Chemical Structure (Tirosint 01)
Chemical structure of Levothyroxine Sodium, showing the molecular arrangement including iodinated aromatic rings, an ether linkage, and a sodium carboxylate group with hydration.*
FDA Label Image

Figure A (Tirosint 02)

Figure A (Tirosint 02)
An instructional illustration showing two hands opening a sealed foil pouch, presumably to access the enclosed product inside. The image emphasizes the action of peeling back the pouch's seal.*
FDA Label Image

Figure B (Tirosint 03)

Figure B (Tirosint 03)
An instructional illustration showing a person holding and separating individual plastic ampules from a strip, demonstrating how to open single-dose ampules used for oral solution administration.*
FDA Label Image

Figure C (Tirosint 04)

Figure C (Tirosint 04)
An instructional diagram showing hands removing or attaching the cap of a small bottle or container. The illustration conveys the proper method to open or close the bottle securely, as part of product usage directions.*
FDA Label Image

Figure D (Tirosint 05)

Figure D (Tirosint 05)
An instructional illustration showing a hand holding a dropper with a liquid dose above a cup of water, demonstrating how to add the liquid medication to the water for oral administration.*
FDA Label Image

Figure E (Tirosint 06)

Figure E (Tirosint 06)
An instructional line drawing depicting a hand holding an oral dropper bottle positioned near an open mouth, illustrating the method for administering oral liquid medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.